Unknown

Dataset Information

0

Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study.

ABSTRACT: A series of new analogs of 3,5-dihydroxybenzoyl-hydrazineylidene conjugated to different methoxyphenyl triazole (11a-n) synthesized using click reaction. The structures of all synthesized compounds were characterized by FTIR, 1H, 13C-NMR spectroscopy, and CHO analysis. The tyrosinase inhibitory potential of the synthesized compounds was studied. The newly synthesized scaffolds were found to illustrate the variable degree of the inhibitory profile, and the most potent analog of this series was that one bearing 4-methoxyphenyl moiety, and exhibited an IC50 value of 55.39 ± 4.93 µM. The kinetic study of the most potent derivative reveals a competitive mode of inhibition. Next, molecular docking studies were performed to understand the potent inhibitor's binding mode within the enzyme's binding site. Molecular dynamics simulations were accomplished to further investigate the orientation and binding interaction over time and the stability of the 11m-tyrosinase complex.

SUBMITTER: Bagheri A 

PROVIDER: S-EPMC10794188 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study.

Bagheri Azzam A   Moradi Shahram S   Iraji Aida A   Mahdavi Mohammad M  

Scientific reports 20240117 1

A series of new analogs of 3,5-dihydroxybenzoyl-hydrazineylidene conjugated to different methoxyphenyl triazole (11a-n) synthesized using click reaction. The structures of all synthesized compounds were characterized by FTIR, <sup>1</sup>H, <sup>13</sup>C-NMR spectroscopy, and CHO analysis. The tyrosinase inhibitory potential of the synthesized compounds was studied. The newly synthesized scaffolds were found to illustrate the variable degree of the inhibitory profile, and the most potent analog  ...[more]

Similar Datasets

Unknown In Vitro and In Silico Studies of Maculosin as a Melanogenesis and Tyrosinase Inhibitor.
| S-EPMC11858074 | biostudies-literature
Unknown Acetophenone-Based 3,4-Dihydropyrimidine-2(1H)-Thione as Potential Inhibitor of Tyrosinase and Ribonucleotide Reductase: Facile Synthesis, Crystal Structure, In-Vitro and In-Silico Investigations.
| S-EPMC9658835 | biostudies-literature
Unknown Elucidating the Role of Santalol as a Potent Inhibitor of Tyrosinase: In Vitro and In Silico Approaches.
| S-EPMC9786741 | biostudies-literature
Unknown Evaluation of caffeine as inhibitor against collagenase, elastase and tyrosinase using in silico and in vitro approach.
| S-EPMC6493221 | biostudies-literature
Unknown Novel Tripeptides as Tyrosinase Inhibitors: In Silico and In Vitro Approaches
| S-EPMC11677486 | biostudies-literature
Unknown Evaluation of the Novel Synthetic Tyrosinase Inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) In Vitro and In Silico.
| S-EPMC6321646 | biostudies-literature
Unknown Hop Tannins as Multifunctional Tyrosinase Inhibitor: Structure Characterization, Inhibition Activity, and Mechanism.
| S-EPMC9027561 | biostudies-literature
Unknown In vitro and in silico insights into tyrosinase inhibitors with (E)-benzylidene-1-indanone derivatives.
| S-EPMC6944710 | biostudies-literature
Unknown Structure-Based In Silico Screening of Marine Phlorotannins for Potential Walrus Calicivirus Inhibitor.
| S-EPMC10647355 | biostudies-literature
Unknown Design, synthesis, and <i>in vitro</i> and <i>in silico</i> study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors.
| S-EPMC11378339 | biostudies-literature